NCT00144456View on ClinicalTrials.gov

A New Active Vitamin D, ED-71 for Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

1,056

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions
Osteoporosis
Interventions
DRUG

ED-71

0.75μg/day(p.o.)for 144 weeks

DRUG

Alfacalcidol

1.0μg/day(p.o.)for 144 weeks

DRUG

ED-71 placebo

0 μg/day(p.o.)for 144 weeks

DRUG

Alfacalcidol placebo

0 μg/day(p.o.)for 144 weeks

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY